Clinical Trial Update: Exploratory Study on the Application of Molecular Residual Disease (MRD) in Postoperative Treatment of Gastric Cancer [EARLY_Phase 1]

View source ↗

Summary

This clinical trial update describes an early-phase exploratory study evaluating the use of molecular residual disease (MRD) to guide postoperative treatment fo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Gastric Adenocarcinoma | EARLY_Phase 1 | Status: RECRUITING